Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug updates delivery applications and enhanced translational potential

被引:74
作者
Agrahari, Vibhuti [1 ]
Burnouf, Pierre-Alain [2 ]
Burnouf, Thierry [3 ,4 ,5 ]
Agrahari, Vivek [6 ]
机构
[1] Shenandoah Univ, Bernard J Dunn Sch Pharm, Winchester, VA USA
[2] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
[3] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Shin St, Taipei 11031, Taiwan
[4] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan
[5] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei, Taiwan
[6] Eastern Virginia Med Sch, CONRAD, 1911 North Ft Myer Dr,Suite 900, Arlington, VA 22209 USA
关键词
Nanoparticles; Cell-based nanocarriers; Neurodegenerative disorders; Blood-brain barrier; Physicochemical properties; Cell-culture media; Protein-corona; Biological proteins; Characterization methods; NANOPARTICLE-PROTEIN CORONA; FETAL BOVINE SERUM; CENTRAL-NERVOUS-SYSTEM; HUMAN PLATELET LYSATE; 2-DIMENSIONAL GEL-ELECTROPHORESIS; SOLID LIPID NANOPARTICLES; HUMAN CEREBROSPINAL-FLUID; PREFORMED ALBUMIN CORONA; AQUEOUS-HUMOR PROTEINS; MESENCHYMAL STEM-CELLS;
D O I
10.1016/j.addr.2019.02.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanocarriers (synthetic/cell-based have attracted enormous interest for various therapeutic indications, including neurodegenerative disorders. A broader understanding of the impact of nanomedicines design is now required to enhance their translational potential. Nanoformulations in vivo journey is significantly affected by their physicochemical properties including the size, shape, hydrophobicity, elasticity, and surface charge/chemistry/morphology, which play a role as an interface with the biological environment. Understanding protein corona formation is crucial in characterizing nanocarriers and evaluating their interactions with biological systems. In this review, the types and properties of the brain-targeted nanocarriers are discussed. The biological factors and nanocarriers properties affecting their in vivo behavior are elaborated. The compositional description of cell culture and biological matrices, including proteins potentially relevant to protein corona built-up on nanoformulation especially for brain administration, is provided. Analytical techniques of characterizing nanocarriers in complex matrices, their advantages, limitations, and implementation challenges in industrial GMP environment are discussed. The uses of orthogonal complementary characterization approaches of nanocarriers are also covered. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 180
页数:35
相关论文
共 316 条
[1]   Blood-brain barrier structure and function and the challenges for CNS drug delivery [J].
Abbott, N. Joan .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) :437-449
[2]   Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice [J].
Adank, Danielle N. ;
Lunzer, Mary M. ;
Lensing, Cody J. ;
Wilber, Stacey L. ;
Gancarz, Amy M. ;
Haskell-Luevano, Carrie .
ACS CHEMICAL NEUROSCIENCE, 2018, 9 (02) :320-327
[3]   Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy [J].
Aggarwal, Parag ;
Hall, Jennifer B. ;
McLeland, Christopher B. ;
Dobrovolskaia, Marina A. ;
McNeil, Scott E. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (06) :428-437
[4]   Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities [J].
Agrahari, Vibhuti ;
Agrahari, Vivek .
DRUG DISCOVERY TODAY, 2018, 23 (05) :974-991
[5]   Extracellular Microvesicles as New Industrial Therapeutic Frontiers [J].
Agrahari, Vivek ;
Agrahari, Vibhuti ;
Burnouf, Pierre-Alain ;
Chew, Chee Ho ;
Burnouf, Thierry .
TRENDS IN BIOTECHNOLOGY, 2019, 37 (07) :707-729
[6]   Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches [J].
Agrahari, Vivek ;
Agrahari, Vibhuti ;
Mitra, Ashim K. .
EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (03) :285-289
[7]   Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease [J].
Agrawal, Mukta ;
Ajazuddin ;
Tripathi, Dulal K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Hammarlund-Udenaes, Margareta ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2017, 260 :61-77
[8]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[9]   Effect of Gold Nanoparticle Aggregation on Cell Uptake and Toxicity [J].
Albanese, Alexandre ;
Chan, Warren C. W. .
ACS NANO, 2011, 5 (07) :5478-5489
[10]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515